[Primary immunodeficiencies and malignant proliferations (author's transl)].

Area of Science:

• Immunology
• Oncology
• Genetics

Context:

• Primary immune deficiencies (PIDs) are rare genetic disorders impairing the immune system's function.
• Individuals with PIDs exhibit a significantly elevated risk of developing various cancers compared to the general population.
• Specific PIDs like Wiskott-Aldrich syndrome, ataxia telangiectasia, and common variable immunodeficiency show a higher predisposition to malignancies.

Purpose:

• To investigate the epidemiological link between primary immune deficiencies and the occurrence of malignant proliferative diseases.
• To analyze the types of malignancies most frequently observed in PID patients.
• To evaluate the underlying immunological mechanisms contributing to cancer development in PIDs.

Summary:

• Malignant proliferative diseases are substantially more common in patients with primary immune deficiencies.
• Malignant lymphomas represent a disproportionately high fraction (two-thirds) of these cancers.
• The high incidence of lymphomas supports a role for chronic antigenic stimulation in cancer development within immune-compromised individuals, rather than solely faulty immune surveillance.

Impact:

• Highlights the critical need for vigilant cancer screening and management in patients diagnosed with primary immune deficiencies.
• Provides insights into the pathogenesis of cancer in the context of immune dysregulation.
• Suggests that therapeutic strategies targeting immune regulation and reducing antigenic load may be beneficial in preventing or treating malignancies in PID patients.